In heart failure, impairment of the bAR system contributes to the dysfunction. Cardiac transplantation is an accepted treatment for severe heart failure; however, myocardial dysfunction is also a problem following this surgical procedure. Increasing bAR signaling properties represents a potential novel therapeutic intervention to improve cardiac function after transplantation and to expand the donor pool. This proposal, capitalizing on the investigator s recent discoveries that cardiac-overexpression of either b2-ARs or inhibitors of bAR desensitization in transgenic mice causes marked improvement of in vivo LV contractility, is formulated to investigate whether these genetic manipulations will render a similar effect if delivered exogenously to donor hearts prior to transplantation, using an adenoviral vector. Direct access to the donor heart prior to surgery provides a unique opportunity for such gene transfer experiments. The central hypothesis to be tested is that alteration in myocardial bAR signaling exists in the transplanted heart, and correcting these alterations will result in improved performance of the graft. To test this hypothesis, a surgical rat heterotopic transplant model and an intra-coronary adenoviral gene delivery system will be utilized.
Specific aims are: 1) To optimize adenoviral mediated gene delivery to the transplanted myocardium and to characterize the level of dysfunction of bAR signaling in the transplanted rat heart. 2) To determine the physiological functional effects of delivered bAR-based adenoviral genes to the transplanted rat heart. 3) To determine whether alterations in bAR signaling play a role in causing the cellular injury and physiologic dysfunction associated with acute graft rejection.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL059533-03
Application #
6139277
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1998-01-01
Project End
2000-12-31
Budget Start
2000-01-01
Budget End
2000-12-31
Support Year
3
Fiscal Year
2000
Total Cost
$224,771
Indirect Cost
Name
Duke University
Department
Surgery
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Bathgate-Siryk, Ashley; Dabul, Samalia; Pandya, Krunal et al. (2014) Negative impact of ?-arrestin-1 on post-myocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal mechanisms. Hypertension 63:404-12
Lymperopoulos, Anastasios; Rengo, Giuseppe; Koch, Walter J (2013) Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res 113:739-53
Boucher, Matthieu; Pesant, Stephanie; Lei, Yong Hong et al. (2008) Simultaneous administration of insulin-like growth factor-1 and darbepoetin alfa protects the rat myocardium against myocardial infarction and enhances angiogenesis. Clin Transl Sci 1:13-20
Pleger, Sven T; Harris, David M; Shan, Changguang et al. (2008) Endothelial S100A1 modulates vascular function via nitric oxide. Circ Res 102:786-94
Hata, Jonathan A; Williams, Matthew L; Schroder, Jacob N et al. (2006) Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading. J Card Fail 12:360-8
Pleger, S T; Most, P; Heidt, B et al. (2006) S100A1 gene transfer in myocardium. Eur J Med Res 11:418-22
Tevaearai, Hendrik T; Walton, G Brant; Keys, Janelle R et al. (2005) Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1). J Gene Med 7:1172-7
Pleger, Sven T; Remppis, Andrew; Heidt, Beatrix et al. (2005) S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. Mol Ther 12:1120-9
Kettlewell, S; Most, P; Currie, S et al. (2005) S100A1 increases the gain of excitation-contraction coupling in isolated rabbit ventricular cardiomyocytes. J Mol Cell Cardiol 39:900-10
Most, Patrick; Boerries, Melanie; Eicher, Carmen et al. (2005) Distinct subcellular location of the Ca2+-binding protein S100A1 differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes. J Cell Sci 118:421-31

Showing the most recent 10 out of 38 publications